KP Tissue Inc. (TSE:KPT – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$11.68 and traded as high as C$12.93. KP Tissue shares last traded at C$12.80, with a volume of 5,491 shares changing hands.
Wall Street Analyst Weigh In
A number of analysts have recently commented on KPT shares. TD upped their target price on shares of KP Tissue from C$12.00 to C$14.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Desjardins lifted their price target on shares of KP Tissue from C$12.00 to C$12.50 and gave the company a “hold” rating in a research report on Friday, May 15th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, KP Tissue presently has a consensus rating of “Hold” and an average price target of C$12.12.
Read Our Latest Research Report on KPT
KP Tissue Trading Down 0.8%
KP Tissue (TSE:KPT – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported C$0.22 earnings per share (EPS) for the quarter. On average, research analysts forecast that KP Tissue Inc. will post 0.4398964 EPS for the current year.
KP Tissue Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 15th were issued a dividend of $0.21 per share. The ex-dividend date was Tuesday, June 30th. This represents a $0.84 annualized dividend and a dividend yield of 6.6%. KP Tissue’s dividend payout ratio (DPR) is presently 80.00%.
Insider Activity
In related news, Director David A. Spraley sold 3,668 shares of the company’s stock in a transaction dated Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total value of C$48,784.40. Following the transaction, the director owned 15,712 shares in the company, valued at C$208,969.60. The trade was a 18.93% decrease in their position. Over the last ninety days, insiders sold 6,668 shares of company stock valued at $87,644. 0.14% of the stock is owned by insiders.
About KP Tissue
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Recommended Stories
- Five stocks we like better than KP Tissue
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
